90 results match your criteria: "Complejo Hospitalario Carlos Haya[Affiliation]"
J Eur Acad Dermatol Venereol
February 2023
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain.
Pediatr Dermatol
November 2018
Department of Dermatology, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.
Background: Recent reports indicate that tufted angioma is a rare vascular neoplasm that manifests more frequently at birth than previously thought. Few studies specifically address congenital presentation.
Objectives: We analyzed the clinicopathological characteristics, clinical course, and treatment of congenital tufted angioma (cTA) and evaluated variables that were indicative of problematic lesions.
Crit Rev Oncol Hematol
October 2018
Radiation Oncology Department, Complejo Hospitalario Carlos Haya, Avenida de Carlos Haya, s/n, 29010 Málaga, Spain.
Head Neck Cancer of Unknown Primary (HNCUP) is a rare condition, representing approximately 5-10% of all head neck cancers. Radiotherapy, adjuvant or radical, is usually employed in the treatment of those patients. To date, no specific guidelines for the optimal definition of the target volume to be irradiated have been published.
View Article and Find Full Text PDFMed Intensiva (Engl Ed)
October 2018
Servicio de Medicina Intensiva, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
The project "Commitment to Quality of Scientific Societies", promoted since 2013 by the Spanish Ministry of Health, seeks to reduce unnecessary health interventions that have not proven effective, have little or doubtful effectiveness, or are not cost-effective. The objective is to establish the "do not do" recommendations for the management of critically ill patients. A panel of experts from the 13 working groups (WGs) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) was selected and nominated by virtue of clinical expertise and/or scientific experience to carry out the recommendations.
View Article and Find Full Text PDFBr J Haematol
September 2016
Department of Haematology, Hospital Duran i Reynals of Barcelona, Barcelona, Spain.
The management of recurrent/refractory (R/R) Hodgkin lymphoma (HL) remains challenging. Previously published data have shown some efficacy of rituximab in this setting. The purpose of this phase II trial was to investigate the activity of ofatumumab in combination with etoposide, steroids, cytarabine and cisplatin (O-ESHAP) in 62 patients with R/R classical HL.
View Article and Find Full Text PDFExp Dermatol
April 2016
Department of Bioengineering, Tissue Engineering and Regenerative Medicine Group (TERMeG), Universidad Carlos III de Madrid, Madrid, Spain.
Epidermolysis bullosa with pyloric atresia (EB-PA) is a rare autosomal recessive hereditary disease with a variable prognosis from lethal to very mild. EB-PA is classified into Simplex form (EBS-PA: OMIM #612138) and Junctional form (JEB-PA: OMIM #226730), and it is caused by mutations in ITGA6, ITGB4 and PLEC genes. We report the analysis of six patients with EB-PA, including two dizygotic twins.
View Article and Find Full Text PDFActas Dermosifiliogr
June 2014
LA-SER Outcomes, Oviedo, España. Electronic address:
Introduction And Objectives: To analyze the triggers of atopic dermatitis (AD), adherence to medical recommendations, disease control, and health-related quality of life (HRQOL) from the patient's perspective.
Patients And Methods: This was a multicenter, cross-sectional, epidemiological study with the participation of adults (age >16 years; n=125) and children (age, 2-15 years, n=116). Patients had a history of at least 12 months of moderate to severe AD with a moderate to severe flare (Investigator Global Assessment score>2) at the time of recruitment.
Pediatr Dermatol
January 2015
Department of Dermatology, Hospital Materno-Infantil, Complejo Hospitalario Carlos Haya, Málaga, Spain.
Transient neonatal zinc deficiency (TNZD) has a clinical presentation similar to that of acrodermatitis enteropathica but is caused by a low zinc concentration in maternal breast milk. TNZD becomes clinically evident during breastfeeding and is resolved by weaning and the introduction of complementary nutrition. We present a 4-month-old girl with TNZD due to a new autosomal dominant mutation (663delC) in the maternal SLC30A2 gene not previously described in the literature.
View Article and Find Full Text PDFMed Clin (Barc)
May 2014
Departamento de Dermatología, Complejo Hospitalario Carlos Haya, Málaga, España.
Med Intensiva
November 2015
Unidad de Cuidados Intensivos, Complejo Hospitalario Carlos Haya, Málaga, España.
Actas Dermosifiliogr
July 2010
Servicio de Dermatología, Complejo Hospitalario Carlos Haya, Málaga, España.
Introduction: Knowledge of the dangers of sun exposure does not always lead to changes in behavior. Failure to make behavioral adjustments is of particular concern in high-risk patients.
Objectives: a) To assess the impact of melanoma diagnosis on knowledge, attitudes, and behaviors relating to sun protection, and b) to identify factors that could influence sun protection behaviors.
Med Clin (Barc)
July 2011
Servicio de Dermatología, Complejo Hospitalario Carlos Haya, Málaga, España.
Med Clin (Barc)
September 2011
Servicio de Dermatología, Complejo Hospitalario Carlos Haya, Málaga, España.
Int J Dermatol
November 2009
Department of Dermatology, Complejo Hospitalario Carlos Haya, Málaga, Spain.
Actas Dermosifiliogr
December 2009
Servicio de Dermatología, Complejo Hospitalario Carlos Haya, Málaga, España.
Glomus tumor was first described by Wood in 1812 and named as such by Masson in 1924. It is a rare benign vascular tumor of the neuromyoarterial glomus. The triad of cold intolerance, intense paroxysmal pain, and well-defined site of pain is characteristic of the tumor.
View Article and Find Full Text PDFMed Clin (Barc)
January 2011
Servicio de Dermatología, Complejo Hospitalario Carlos Haya, Málaga, España.
Actas Dermosifiliogr
November 2009
Servicio de Dermatología, Complejo Hospitalario Carlos Haya, Málaga, España.
Rev Esp Anestesiol Reanim
December 2009
Servicio de Anestesiología, Reanimación y Terapia del Dolor, Hospital Materno-Infantil, Complejo Hospitalario Carlos Haya, Málaga.
Am J Clin Dermatol
December 2009
Dermatology Department, Complejo Hospitalario Carlos Haya, Málaga, Spain.
A 29-year-old female patient presented with a giant melanoma on the external side of the left arm and concomitant multiple visceral metastases. The patient also had major depression and had avoided a consultation despite the large size of the lesion, delaying the diagnosis and treatment of her melanoma, which as far as we know is the largest, primary cutaneous melanoma ever reported. Excision of the tumor was performed as a palliative treatment and she died 1 month later.
View Article and Find Full Text PDFMed Clin (Barc)
September 2010
Servicio de Dermatología, Complejo Hospitalario Carlos Haya, Málaga, Spain.
Med Clin (Barc)
October 2009
Servicio de Dermatología, Complejo Hospitalario Carlos Haya, Málaga, España.
Med Intensiva
March 2009
Servicio de Cuidados Críticos y Urgencias, Complejo Hospitalario Carlos Haya, Málaga, España.
Med Clin (Barc)
March 2009
Servicio de Dermatología, Complejo Hospitalario Carlos Haya, Málaga, España.
Rev Esp Geriatr Gerontol
October 2008
Presidente de la Sociedad Española de Hipertensión Complejo Hospitalario Carlos Haya, Servicio de Nefrología, Málaga, España.
Actas Dermosifiliogr
October 2008
Servicio de Dermatología, Complejo Hospitalario Carlos Haya, Málaga, España.